Glenmark Pharma Jumps 14% on $700 Million Global Licensing Deal
Glenmark Pharma Jumps 14% on $700 Million Global Licensing Deal — Real Growth or Just Hype? https://g.co/finance/GLENMARK:NSE https://g.co/finance/GLENMARK:NSE In a surprising move, Glenmark Pharmaceuticals surged nearly 14% in today’s trading session, following the announcement of a significant $700 million global licensing agreement. This deal has stirred excitement among investors, but also triggered caution from market … Read more